World's Best Scientists 2026 revealed!
Oncogene
H-index 67

Oncogene

0950-9232

Published by: Springer

https://www.nature.com/onc/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Molecular Biology 21 224 285 37
Genetics 32 89 106 28
Biology and Biochemistry 55 685 682 53
Medicine 201 530 547 53

Additional Metrics

Number of Best Scientists*: 1595
Documents by Best Scientists*: 1237
Top 100 Ranked Scientists*: 46
SCIMAGO H-index: 380
SCIMAGO SJR: 2.489
Impact Factor: 7.3

Overview

Top Research Topics at Oncogene?

Oncogene focuses on Cancer research, Cell biology, Carcinogenesis, Molecular biology and Signal transduction. Cancer research research in it involves the investigation of Cell cycle studies, all of which are linked to disciplines such as Growth factor receptor. The Cell biology works featured in Oncogene incorporate elements from Apoptosis, Transcription factor and Cell growth.

The work on Carcinogenesis tackled in it brings together disciplines like Endocrinology, Cancer cell, Mutation, Downregulation and upregulation and Regulation of gene expression. Oncogene explores issues in Molecular biology which can be linked to other research areas like Gene expression, Mutant, Transfection, Gene and Transcription (biology). It features research on Gene in an attempt to reinforce studies in the field of Genetics.

Protein kinase B and MAPK/ERK pathway are all topics related to Signal transduction research discussed. Metastasis and Breast cancer are among the areas of Cancer tackled. The Phosphorylation study featured falls within the larger field of Biochemistry.

  • Cancer research (47.88%)
  • Cell biology (28.70%)
  • Carcinogenesis (24.55%)

What are the most cited papers published in the journal?

  • Activators and target genes of Rel/NF-kappaB transcription factors. (3516 citations)
  • Cisplatin: mode of cytotoxic action and molecular basis of resistance (2462 citations)
  • Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. (2144 citations)

Research areas of the most cited articles at Oncogene:

The most cited articles investigate studies in Cancer research, Cell biology, Carcinogenesis, Molecular biology and Signal transduction. The published articles focus on Cancer research but sometimes tackle the closely related topic of Cell cycle which is concerned with Cell growth. The most cited papers address concerns in Cell biology which are intertwined with other disciplines, such as Genetics, Biochemistry, Apoptosis and Transcription factor.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Enzyme

The previous edition focused in particular on these issues:

The journal primarily tackles Cancer research, Cancer, Metastasis, Carcinogenesis and Cell biology. Gene knockdown, Cell growth, Cancer cell, Downregulation and upregulation and Breast cancer are some topics wherein Cancer research research discussed in Oncogene have an impact. The Breast cancer study tackling the subject of Triple-negative breast cancer is the focus of it.

Issues in Cancer were discussed, taking into consideration concepts from other disciplines like Cell, Transcriptome, Gene and Immune system. Metastasis research presented in it encompasses a variety of subjects, including Protein kinase B, Pancreatic cancer and In vivo. Some problems in Cell biology that were presented in Oncogene overlapped with concepts under Chromatin and Transcription factor.

The most cited articles from the last journal are:

  • circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma. (16 citations)
  • Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. (15 citations)
  • A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. (14 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Oncogene (based on the number of publications) are:

  • Mien Chie Hung (65 papers) published 4 papers at the last edition, 3 more than at the previous edition,
  • Alfredo Fusco (63 papers) absent at the last edition,
  • Guido Kroemer (59 papers) absent at the last edition,
  • Gordon B. Mills (57 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Jun Yu (57 papers) published 11 papers at the last edition, 6 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Oncogene (based on the number of publications) are:

  • French Institute of Health and Medical Research (731 papers) published 10 papers at the last edition, 2 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (727 papers) published 21 papers at the last edition, 2 less than at the previous edition,
  • National Institutes of Health (725 papers) published 12 papers at the last edition, 5 more than at the previous edition,
  • Harvard University (629 papers) published 10 papers at the last edition, 1 less than at the previous edition,
  • Centre national de la recherche scientifique (383 papers) published 2 papers at the last edition, 5 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.12% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.20% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.44% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 23.86% of all publications and 55.49% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.

    Winnie Fong;Qing Li;Jun Yu

    (2020)
    428 Citations
  • The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment.

    Timothy P. Brown;Pushpak Bhattacharjee;Sabarish Ramachandran;Sathish Sivaprakasam

    (2020)
    184 Citations
  • PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.

    Sajid Khan;Yonghan He;Xuan Zhang;Yaxia Yuan

    (2020)
    184 Citations
  • Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma

    (2020)
    183 Citations
  • Immune-based therapies for hepatocellular carcinoma.

    David J. Pinato;Nadia Guerra;Petros Fessas;Ravindhi Murphy

    (2020)
    177 Citations
  • Heat-shock proteins: chaperoning DNA repair.

    Laurence Dubrez;Laurence Dubrez;Sébastien Causse;Sébastien Causse;Natalia Borges Bonan;Natalia Borges Bonan;Baptiste Dumétier;Baptiste Dumétier

    (2020)
    169 Citations
  • Neurotransmitters: emerging targets in cancer

    Shu-Heng Jiang;Li-Peng Hu;Xu Wang;Jun Li

    (2020)
    167 Citations
  • Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.

    Di He;Di Wang;Ping Lu;Nan Yang

    (2021)
    152 Citations
  • High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma

    Beng Yang;Xiaode Feng;Hua Liu;Rongliang Tong

    (2020)
    149 Citations
  • Role of p38 MAP kinase in cancer stem cells and metastasis

    (2022)
    135 Citations

Related Online Degrees & Career Pathways

For students interested in broadening their medical knowledge or exploring allied health careers, online programs offer flexible options that complement traditional medical studies. Pursuing online nutrition degrees can provide a strong foundation in dietary science, crucial for those looking to specialize in preventive medicine or wellness.

Healthcare administration is another vital area with growing demand. Students can enhance their leadership skills through cahme-accredited online mha programs, which prepare graduates for management roles in hospitals and clinics while maintaining rigorous accreditation standards.

For practicing nurses or medical professionals aiming for advanced practice roles without additional clinical hours, there are innovative options like the dnp program without clinical hours. These programs focus on leadership, policy, and evidence-based practice, ideal for expanding career horizons.

Finally, those interested in the organizational and strategic aspects of healthcare may consider a phd in healthcare management online. This pathway enables professionals to engage in high-level research, policy-making, and executive roles in the health sector.

Best Scientists Contributing to This Journal